Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dr. Diab is a clinical investigator whose research is focused on developing new Immunotherapeutic Strategies that will improve clinical outcomes in patients. Building on his extensive background in immunology in general and tumor immunology specifically, Dr. Diab is leading multiple clinical trials involving novel vaccines for patients with Melanoma, In addition he is leading a program for Interventional Immunotherapy that was established to develop Intratumoral Therapeutic strategies in combination with Systemic therapy; which not only designed to improve clinical outcome but also allow us to better understand the dynamics of each patient immune response to the tumor. These strategies include Tumor ablation such as Cryoablation, RFA or Radiation therapy as well as direct intratumoral injection of immune modulation agents such as TLR agonists and other immune-stimulating agents.
Vaccine development, Intratumoral therapy, and Immunotherapy.